Structure determination has already proven useful for lead optimization and direct drug design. 
. [3] . For this reason, it has been much more difficult to recombinantly express membrane proteins in quantitatively and qualitatively sufficient amounts compared with those of their soluble counterparts. Moreover, as the membrane proteins are embedded in membranes detergents are required for purification, which affects both yields and stability of the protein [4] . Furthermore, structure determination by X-ray crystallography has been negatively affected by low yields and presence of detergents [5] . Membrane proteins also possess characteristically flexible regions and short hydrophilic loops, which reduces significantly the potential crystal contacts and thereby crystallization success. The application of nuclear magnetic resonance (NMR) for structure determination is also more complicated for membrane proteins. Typically, only a single high-resolution structure has been solved for the family of GPCRs consisting of some 800 members [6] . Moreover 
This discrepancy relates mainly to the topological composition of membrane proteins. A large number of them such as G protein-coupled receptors (GPCRs) and ion channels have a topology, including multispanning transmembrane domains

Structure determination and drug discovery
Structural biology has facilitated drug discovery already for some time. The application of structurebased drug design has become relatively common in lead optimization [7] . Structural knowledge of proteins and their ligands has aided in improving drug potency and selectivity [8] . This approach has resulted in faster definition of drug-binding properties and has made it easier to identify 'hit' compounds through screening programs [9] . Both the use of X-ray crystallography and NMR have allowed high throughput approaches for structure-based lead discovery [10] . Rapid structure resolution of protein-ligand complexes has been obtained applying such automated procedures as AutoSolve ® [11] . The technology revealed that from cocktails of 100 molecules, electron density variations could be used to distinguish their different shapes [12] . 
Cell-free translation
The recent development of cell-free translation systems has made them attractive and competitive [21] [24] . Recently, the first demonstration of cell-free translation-based high-resolution structure determination came from solving the X-ray structure of the EmrE multidrug transporter complex [25] .
Bacterial expression Expression in E. coli
The by far most commonly used expression system is based on E. coli [26] . The [36] . However, expression of the human KDEL receptor resulted in yields less than 0.1% of the total membrane protein [36] . In a recent study, 11 yeast mitochondrial transporter proteins were expressed at structural biology compatible levels in L. lactis [37] . Expression levels could be enhanced 10- [42] . [44] , ␣1-Antitrypsin [45] , human ␣-interferon [46] and‚ ␤-endorphin [47] . S. cerevisiae has also been frequently used for expression of membrane proteins. For instance, the yeast ␣-factor Ste2p receptor [48] and human dopamine D1A receptor [49] [62] . Finally, the mammalian Shaker voltage-dependent K + channel was expressed in P. pastoris, which allowed efficient purification and high-resolution structure determination [63] .
Expression in yeast cells
Expression in insect cells Baculovirus The second most commonly used expression system after E. coli is based on Baculovirus vectors for infection of insect cell lines [64]. High expression levels of topologically different recombinant proteins have been obtained in different insect cell lines from Spodoptera frugiperda (Sf9 and Sf21), Mamestra brassica and Trichoplusia ni (high five). Eukaryotic and especially mammalian membrane proteins have been relatively favourably expressed in insect cells because of the similar post-translational processing mechanisms present in insect cells. In this context, expression of rhodopsin resulted in 80% functional
receptor and yields up to 6 mg/l [65] . GPCRs have been popular targets for baculovirus expression, and in many cases expression levels of 40-60 pmol/mg have been achieved [66] . Expression levels between 1 pmol/mg and 250 pmol/mg were obtained in a study of 16 GPCRs in three insect cell lines [67] . [88] . The easy and rapid production of recombinant SFV stocks has made it feasible to express a large number of proteins in parallel in various mammalian cell lines [89] . In this context, 103 GPCRs were evaluated for expression levels in three mammalian cell lines in a structural genomics program described in more detail below [90] . As large-scale production in mammalian suspension cultures has been established for SFV, ligand-gated ion channels [91] and GPCRs [92] have been expressed at levels of 5-10 mg/L, purified and subjected to structural biology. [94] . Solubilization by detergents is a complicated process, and a vast number of detergents have been tested. In general, detergents are highly target-specific, which means that each target has to be screened for appropriate detergents [95] . Commonly used detergents are CHAPS (3-[(3-cholamidopropyl) dimethylaminio]-1-propane-sulfonate, Triton X-100, n-Octylglucoside, n-Nonylglucoside, n-Dodecylmaltoside and FOS-Choline and cocktails thereof [95] .
Other insect vectors In addition to Baculovirus-based systems, expression of recombinant proteins has been conducted mainly in stable insect cell lines, typically Drosophila Schneider cells [68]. A soluble deglycosylated form of the human interleukin 5 (IL-5) alpha subunit was expressed in Drosophila cells in active form, purified and a 2.6 Å resolution crystal structure was solved [69]. Schneider cells have also been used as hosts for GPCR expression. For instance, the human mu opioid receptor (hMOR) showed a similar pharmacological profile as in mammalian cells and the functional coupling to G proteins was demonstrated by cAMP stimulation and GTP␥S binding assays [70]. Engineering of an N-terminal EGFP tag to the hMOR for localization studies suggested that a large number of receptors were retained in intracellular compartments and not present on the plasma membrane.
Expression in mammalian cells
Protein purification
Structure determination X-ray crystallography
The highest structure resolution, below 2 Å, can be achieved by X-ray crystallography only. Although a large number of X-ray structures are available today, crystallography still faces some serious challenges. This is mainly due to the success of purification and the stability of the purified protein. Needless to say, membrane proteins present additional obstacles as the purification is often inefficient and the presence of detergents may interfere with the crystallization process. However, major development has taken place with the introduction of automation and miniaturization [96] . The reduction of volumes to nanoliter scale has significantly reduced the material quantities required, and together with high throughput crystallization in 96 micro plate and higher format has permitted screening of numerous crystallization parameters and conditions in parallel [97] 
Nuclear magnetic resonance
Complementary to X-ray crystallography, NMR can serve structure determination [98] [101] .
Electron microscopy
In addition to X-ray crystallography and NMR, electron microscopy (EM) and atomic force microscopy (AFM) can also be used to obtain information at atomic resolution levels for protein structures [102] . Cryoelectron microscopy has successfully been applied for reconstituted membrane proteins in 2D crystals. In this context, a 3.5 Å resolution was achieved for bacteriorhodopsin [103] and aquaporin AQP1 [104] . Despite this rather low resolution it was possible to define the atomic structure, which was subsequently confirmed by X-ray crystallography. Structural characterization by AFM of polypeptide loops on native and reconstituted membranes in aqueous solutions demonstrated that rhodopsin in the disc membranes of vertebrate photoreceptor rod outer segments occurred as dimers or higher oligomeric forms [105] . [17] and HIV [16] drugs. Structure determination has also become a routine tool in lead discovery and optimization [7] . 
Structural genomics programs
